By Ben Hirschler. LONDON | Tue Jun 18, 2013 12:50pm EDT. LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief ...
AstraZeneca plans Cambridge transplant
The Times (subscription)
AstraZeneca sets up new headquarters in Cambridge
Related articles »